Myelodysplastic syndromes (MDS) comprise the most common malignant blood disorder. MDS are increasing in frequency owing to an ageing population and increased awareness of these diseases.

Myelodysplastic syndromes (MDS) are clonal disorders of ... to disease progression to acute myeloid leukemia. Various cell types contribute to dysregulation of immune responses in MDS.

These tips can help you better manage MDS fatigue. Myelodysplastic syndromes (MDS) is a type of cancer that shows up as a group of conditions affecting your bone marrow and blood. “Myelo ...

Roughly one in 14 people with lower-risk myelodysplastic syndromes (LR-MDS) have an infection in the first year after ...

Treatment with bexmarilimab and Vidaza elicited high overall response rates in both frontline and relapsed/refractory ...

Myelodysplastic syndromes, a group of bone marrow disorders characterised by the underproduction of one or more types of blood cells due to dysfunction of the marrow, are diagnosed in around 2000 ...

Myelodysplastic syndromes (MDS), are diagnosed in around 2000 people each year in England and are characterised by the underproduction of one or more types of blood cells due to dysfunction of the ...